N, K., LM, M., M, S., O, P., & FL, A. (2026). Policy changes in opioid agonist therapy and impacts on HIV and hepatitis C prevention in Canadian federal prisons. Lancet regional health. Americas, 58, 101498. https://doi.org/10.1016/j.lana.2026.101498
Chicago Style (17th ed.) CitationN, Kronfli, Madden LM, Stoové M, Price O, and Altice FL. "Policy Changes in Opioid Agonist Therapy and Impacts on HIV and Hepatitis C Prevention in Canadian Federal Prisons." Lancet Regional Health. Americas 58 (2026): 101498. https://doi.org/10.1016/j.lana.2026.101498.
MLA (9th ed.) CitationN, Kronfli, et al. "Policy Changes in Opioid Agonist Therapy and Impacts on HIV and Hepatitis C Prevention in Canadian Federal Prisons." Lancet Regional Health. Americas, vol. 58, 2026, p. 101498, https://doi.org/10.1016/j.lana.2026.101498.